Year |
Citation |
Score |
2022 |
Jiang H, Muir RK, Gonciarz RL, Olshen AB, Yeh I, Hann BC, Zhao N, Wang YH, Behr SC, Korkola JE, Evans MJ, Collisson EA, Renslo AR. Ferrous iron-activatable drug conjugate achieves potent MAPK blockade in KRAS-driven tumors. The Journal of Experimental Medicine. 219. PMID 35262628 DOI: 10.1084/jem.20210739 |
0.666 |
|
2020 |
Zhao N, Huang Y, Wang YH, Muir RK, Chen YC, Hooshdaran N, Wei J, Viswanath P, Seo Y, Ruggero D, Renslo AR, Evans MJ. Ferronostics: Measuring Tumoral Ferrous Iron with PET to Predict Sensitivity to Iron-Targeted Cancer Therapies. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 33246980 DOI: 10.2967/jnumed.120.252460 |
0.706 |
|
2020 |
Huff TC, Camarena V, Sant DW, Wilkes Z, Van Booven D, Aron AT, Muir RK, Renslo AR, Chang CJ, Monje PV, Wang G. Oscillatory cAMP signaling rapidly alters H3K4 methylation. Life Science Alliance. 3. PMID 31882444 DOI: 10.26508/lsa.201900529 |
0.594 |
|
2020 |
Jiang H, Muir R, Renslo A, Collisson E. Abstract 6419: Novel ferrous iron-dependent prodrug strategy for KRAS-driven pancreatic cancer: The preclinic efficacy and safety test Cancer Research. 80: 6419-6419. DOI: 10.1158/1538-7445.Am2020-6419 |
0.673 |
|
2019 |
Blank B, Talukder P, Muir R, Green E, Skaar EP, Renslo AR. Targeting Mobilization of Ferrous Iron in Pseudomonas aeruginosa Infection with an Iron(II)-Caged LpxC Inhibitor. Acs Infectious Diseases. PMID 31140267 DOI: 10.1021/Acsinfecdis.9B00057 |
0.553 |
|
2019 |
Muir RK, Zhao N, Wei J, Wang YH, Moroz A, Huang Y, Chen YC, Sriram R, Kurhanewicz J, Ruggero D, Renslo AR, Evans MJ. Measuring Dynamic Changes in the Labile Iron Pool in Vivo with a Reactivity-Based Probe for Positron Emission Tomography. Acs Central Science. 5: 727-736. PMID 31041393 DOI: 10.1021/Acscentsci.9B00240 |
0.744 |
|
2017 |
Camarena V, Sant DW, Huff TC, Mustafi S, Muir RK, Aron AT, Chang CJ, Renslo AR, Monje P, Wang G. cAMP signaling regulates DNA hydroxymethylation by augmenting the intracellular labile ferrous iron pool. Elife. 6. PMID 29239726 DOI: 10.7554/Elife.29750 |
0.62 |
|
2017 |
Camarena V, Sant DW, Huff TC, Mustafi S, Muir RK, Aron AT, Chang CJ, Renslo AR, Monje PV, Wang G. Author response: cAMP signaling regulates DNA hydroxymethylation by augmenting the intracellular labile ferrous iron pool Elife. DOI: 10.7554/Elife.29750.032 |
0.644 |
|
Show low-probability matches. |